Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E B Chaibi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biochimica Et Biophysica Acta|March 21, 1998
Clinical inhibitor-resistant mutants of the beta-lactamase TEM-1 at amino-acid position 69. Kinetic analysis and molecular modellingE B Chaibi, J Péduzzi, S Farzaneh, et al.
Antimicrobial Agents and Chemotherapy|February 27, 1999
Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron geneL Poirel, T Naas, M Guibert, et al.
Antimicrobial Agents and Chemotherapy|November 26, 1997
Inhibitor-resistant TEM (IRT) beta-lactamases with different substitutions at position 244L Bret, E B Chaibi, C Chanal-Claris, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Chromosomally encoded ampC-type beta-lactamase in a clinical isolate of Proteus mirabilisL Bret, C Chanal-Claris, D Sirot, et al.
Antimicrobial Agents and Chemotherapy|July 2, 1999
Biochemical-genetic analysis and distribution of FAR-1, a class A beta-lactamase from Nocardia farcinicaF Laurent, L Poirel, T Naas, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1996
Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) beta-lactamaseS Farzaneh, E B Chaibi, J Peduzzi, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2000
Characterization of TEM-56, a novel beta-lactamase produced by a Klebsiella pneumoniae clinical isolateC Neuwirth, R Labia, E Siebor, et al.
Antimicrobial Agents and Chemotherapy|July 2, 1999
Molecular characterization of TEM-59 (IRT-17), a novel inhibitor-resistant TEM-derived beta-lactamase in a clinical isolate of Klebsiella oxytocaH Bermudes, F Jude, E B Chaibi, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1997
A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolateD Sirot, C Recule, E B Chaibi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta|March 21, 1998
Clinical inhibitor-resistant mutants of the beta-lactamase TEM-1 at amino-acid position 69. Kinetic analysis and molecular modellingE B Chaibi, J Péduzzi, S Farzaneh, et al.
Antimicrobial Agents and Chemotherapy|February 27, 1999
Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron geneL Poirel, T Naas, M Guibert, et al.
Antimicrobial Agents and Chemotherapy|November 26, 1997
Inhibitor-resistant TEM (IRT) beta-lactamases with different substitutions at position 244L Bret, E B Chaibi, C Chanal-Claris, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Chromosomally encoded ampC-type beta-lactamase in a clinical isolate of Proteus mirabilisL Bret, C Chanal-Claris, D Sirot, et al.
Antimicrobial Agents and Chemotherapy|July 2, 1999
Biochemical-genetic analysis and distribution of FAR-1, a class A beta-lactamase from Nocardia farcinicaF Laurent, L Poirel, T Naas, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1996
Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) beta-lactamaseS Farzaneh, E B Chaibi, J Peduzzi, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2000
Characterization of TEM-56, a novel beta-lactamase produced by a Klebsiella pneumoniae clinical isolateC Neuwirth, R Labia, E Siebor, et al.
Antimicrobial Agents and Chemotherapy|July 2, 1999
Molecular characterization of TEM-59 (IRT-17), a novel inhibitor-resistant TEM-derived beta-lactamase in a clinical isolate of Klebsiella oxytocaH Bermudes, F Jude, E B Chaibi, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1997
A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolateD Sirot, C Recule, E B Chaibi, et al.
Pageof 1